312 related articles for article (PubMed ID: 25272303)
1. Mesonephric carcinosarcoma involving uterine cervix and vagina: report of 2 cases with immunohistochemical positivity For PAX2, PAX8, and GATA-3.
Roma AA
Int J Gynecol Pathol; 2014 Nov; 33(6):624-9. PubMed ID: 25272303
[TBL] [Abstract][Full Text] [Related]
2. Differential patterns of PAX8, p16, and ER immunostains in mesonephric lesions and adenocarcinomas of the cervix.
Goyal A; Yang B
Int J Gynecol Pathol; 2014 Nov; 33(6):613-9. PubMed ID: 25272301
[TBL] [Abstract][Full Text] [Related]
3. A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract.
Pors J; Cheng A; Leo JM; Kinloch MA; Gilks B; Hoang L
Am J Surg Pathol; 2018 Dec; 42(12):1596-1606. PubMed ID: 30148742
[TBL] [Abstract][Full Text] [Related]
4. PAX8 and PAX2 expression in endocervical adenocarcinoma in situ and high-grade squamous dysplasia.
Shukla A; Thomas D; Roh MH
Int J Gynecol Pathol; 2013 Jan; 32(1):116-21. PubMed ID: 23202787
[TBL] [Abstract][Full Text] [Related]
5. PAX2 and PAX8: useful markers for metastatic effusions.
Waters L; Crumley S; Truong L; Mody D; Coffey D
Acta Cytol; 2014; 58(1):60-6. PubMed ID: 24334997
[TBL] [Abstract][Full Text] [Related]
6. Differential Expression Patterns of GATA3 in Uterine Mesonephric and Nonmesonephric Lesions.
Roma AA; Goyal A; Yang B
Int J Gynecol Pathol; 2015 Sep; 34(5):480-6. PubMed ID: 25851711
[TBL] [Abstract][Full Text] [Related]
7. Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-β.
Kenny SL; McBride HA; Jamison J; McCluggage WG
Am J Surg Pathol; 2012 Jun; 36(6):799-807. PubMed ID: 22456609
[TBL] [Abstract][Full Text] [Related]
8. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
9. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations.
Yemelyanova A; Gown AM; Wu LS; Holmes BJ; Ronnett BM; Vang R
Int J Gynecol Pathol; 2014 Sep; 33(5):492-9. PubMed ID: 25083965
[TBL] [Abstract][Full Text] [Related]
10. A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.
Carleton C; Hoang L; Sah S; Kiyokawa T; Karamurzin YS; Talia KL; Park KJ; McCluggage WG
Am J Surg Pathol; 2016 May; 40(5):636-44. PubMed ID: 26685087
[TBL] [Abstract][Full Text] [Related]
11. Carcinosarcoma of the uterine cervix: a rare pathological finding originating from mesonephric remnants.
Ribeiro B; Silva R; Dias R; Patrício V
BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30936330
[TBL] [Abstract][Full Text] [Related]
12. PAX2 and PAX8 expression in primary and metastatic müllerian epithelial tumors: a comprehensive comparison.
Ozcan A; Liles N; Coffey D; Shen SS; Truong LD
Am J Surg Pathol; 2011 Dec; 35(12):1837-47. PubMed ID: 21989345
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of PAX2 and PAX8 expression in salivary gland neoplasms.
Butler RT; Alderman MA; Thompson LD; McHugh JB
Head Neck Pathol; 2015 Mar; 9(1):47-50. PubMed ID: 24771139
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the Utility of PAX8 Immunohistochemical Stain in Diagnosing Endocervical Glandular Lesions.
Liang L; Zheng W; Liu J; Liang SX
Arch Pathol Lab Med; 2016 Feb; 140(2):148-52. PubMed ID: 26910219
[TBL] [Abstract][Full Text] [Related]
15. Tumor rupture as an initial manifestation of malignant mesonephric mixed tumor: a case report and review of the literature.
Tseng CE; Chen CH; Chen SJ; Chi CL
Int J Clin Exp Pathol; 2014; 7(3):1212-7. PubMed ID: 24696739
[TBL] [Abstract][Full Text] [Related]
16. Mesonephric adenocarcinomas of the uterine cervix: a study of 11 cases with immunohistochemical findings.
Silver SA; Devouassoux-Shisheboran M; Mezzetti TP; Tavassoli FA
Am J Surg Pathol; 2001 Mar; 25(3):379-87. PubMed ID: 11224609
[TBL] [Abstract][Full Text] [Related]
17. Malignant mesonephric neoplasms of the uterine cervix. A report of eight cases, including four with a malignant spindle cell component.
Clement PB; Young RH; Keh P; Ostör AG; Scully RE
Am J Surg Pathol; 1995 Oct; 19(10):1158-71. PubMed ID: 7573674
[TBL] [Abstract][Full Text] [Related]
18. Mesonephric Adenocarcinoma of the Uterine Corpus: A Case Report and Diagnostic Pitfall.
Kim SS; Nam JH; Kim GE; Choi YD; Choi C; Park CS
Int J Surg Pathol; 2016 Apr; 24(2):153-8. PubMed ID: 26510860
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of PAX8 and PAX2 immunohistochemistry in the identification of metastatic Müllerian carcinoma in effusions.
Wiseman W; Michael CW; Roh MH
Diagn Cytopathol; 2011 Sep; 39(9):651-6. PubMed ID: 20949455
[TBL] [Abstract][Full Text] [Related]
20. Cervical adenocarcinoma arising in florid mesonephric hyperplasia: report of a case with immunocytochemical studies.
Valente PT; Susin M
Gynecol Oncol; 1987 May; 27(1):58-68. PubMed ID: 2436982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
